254 related articles for article (PubMed ID: 21881509)
1. Pulmonary exacerbations in cystic fibrosis.
Stenbit AE; Flume PA
Curr Opin Pulm Med; 2011 Nov; 17(6):442-7. PubMed ID: 21881509
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary exacerbations in cystic fibrosis.
Rabin HR; Butler SM; Wohl ME; Geller DE; Colin AA; Schidlow DV; Johnson CA; Konstan MW; Regelmann WE;
Pediatr Pulmonol; 2004 May; 37(5):400-6. PubMed ID: 15095322
[TBL] [Abstract][Full Text] [Related]
3. Approach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers.
Kraynack NC; Gothard MD; Falletta LM; McBride JT
Pediatr Pulmonol; 2011 Sep; 46(9):870-81. PubMed ID: 21465675
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.
Flume PA; Mogayzel PJ; Robinson KA; Rosenblatt RL; Quittell L; Marshall BC; ;
Am J Respir Crit Care Med; 2010 Aug; 182(3):298-306. PubMed ID: 20675678
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.
Flume PA; Mogayzel PJ; Robinson KA; Goss CH; Rosenblatt RL; Kuhn RJ; Marshall BC;
Am J Respir Crit Care Med; 2009 Nov; 180(9):802-8. PubMed ID: 19729669
[TBL] [Abstract][Full Text] [Related]
7. The clinical approach to lung disease in patients with cystic fibrosis.
O'Sullivan BP; Flume P
Semin Respir Crit Care Med; 2009 Oct; 30(5):505-13. PubMed ID: 19760538
[TBL] [Abstract][Full Text] [Related]
8. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials.
Mayer-Hamblett N; Saiman L; Lands LC; Anstead M; Rosenfeld M; Kloster M; Fisher L; Ratjen F
Contemp Clin Trials; 2013 Sep; 36(1):99-105. PubMed ID: 23770109
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary exacerbations in CF patients with early lung disease.
Anstead M; Saiman L; Mayer-Hamblett N; Lands LC; Kloster M; Goss CH; Rose L; Burns JL; Marshall B; Ratjen F
J Cyst Fibros; 2014 Jan; 13(1):74-9. PubMed ID: 24029220
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.
Waters VJ; Stanojevic S; Sonneveld N; Klingel M; Grasemann H; Yau YC; Tullis E; Wilcox P; Freitag A; Chilvers M; Ratjen FA
J Cyst Fibros; 2015 Nov; 14(6):755-62. PubMed ID: 25690407
[TBL] [Abstract][Full Text] [Related]
11. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
[TBL] [Abstract][Full Text] [Related]
12. [Early detection of exacerbation of lung infections in patients with cystic fibrosis by means of daily spirometry].
Izbicki G; Trachsel D; Rutishauser M; Perruchoud AP; Tamm M
Schweiz Med Wochenschr; 2000 Sep; 130(39):1361-5. PubMed ID: 11059026
[TBL] [Abstract][Full Text] [Related]
13. Update on treatment of pulmonary exacerbations in cystic fibrosis.
Smyth A
Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
[TBL] [Abstract][Full Text] [Related]
14. Inhaled hypertonic saline as a therapy for cystic fibrosis.
Elkins MR; Bye PT
Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
[TBL] [Abstract][Full Text] [Related]
15. Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.
Kapur N; Masters IB; Chang AB
Respir Med; 2009 Nov; 103(11):1681-7. PubMed ID: 19501498
[TBL] [Abstract][Full Text] [Related]
16. Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis.
Kapur N; Masters IB; Morris PS; Galligan J; Ware R; Chang AB
Pediatr Pulmonol; 2012 Jan; 47(1):68-75. PubMed ID: 21830316
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
[TBL] [Abstract][Full Text] [Related]
18. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
[TBL] [Abstract][Full Text] [Related]
19. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary complications in cystic fibrosis].
Rutishauser M
Schweiz Med Wochenschr; 1991 Jan; 121(4):115-8. PubMed ID: 2003207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
